GlassScriptPhysician profile
George William Gray
NPI 1790183168
$8,389.23
in general payments reported to CMS, 2019-2025
42 companies · $684 in 2025
The $684 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,369 · 2020: $657 · 2021: $1,656 · 2022: $1,701 · 2023: $1,585 · 2024: $736 · 2025: $684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,925 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,925.29 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $966.62 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $900.28 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $780.38 | 2019-2025 | |
| Esperion Therapeutics, INC. | $507.48 | 2020-2023 | Nexletol |
| Glaxosmithkline, LLC. | $506.69 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novartis Pharmaceuticals Corporation | $364.29 | 2019-2025 | |
| Astellas Pharma US INC | $320.20 | 2019-2025 | Veozah, Myrbetriq |
| Amgen INC. | $318.24 | 2019-2025 | Repatha, Otezla |
| Pfizer INC. | $227.32 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $217.47 | 2019-2023 | Lifevest |
| Medtronic Vascular, INC. | $216.77 | 2019 | |
| Boston Scientific Corporation | $216.54 | 2022-2025 | Watchman Flx |
| Kowa Pharmaceuticals America, INC. | $187.56 | 2019-2023 | Seglentis |
| Sunovion Pharmaceuticals INC. | $180.25 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $180.16 | 2019-2023 | Farxiga |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.